|
||||||
|
 | Fusion Gene Summary |
| Fusion Gene ORF analysis |
| Fusion Genomic Features |
| Fusion Protein Features |
| Fusion Gene Sequence |
| Fusion Gene PPI analysis |
| Related Drugs |
| Related Diseases |
Fusion gene:RPL10-PGK1 (FusionGDB2 ID:75285) |
Fusion Gene Summary for RPL10-PGK1 |
 Fusion gene summary |
| Fusion gene information | Fusion gene name: RPL10-PGK1 | Fusion gene ID: 75285 | Hgene | Tgene | Gene symbol | RPL10 | PGK1 | Gene ID | 6138 | 5230 |
| Gene name | ribosomal protein L15 | phosphoglycerate kinase 1 | |
| Synonyms | DBA12|EC45|L15|RPL10|RPLY10|RPYL10 | HEL-S-68p|MIG10|PGKA | |
| Cytomap | 3p24.2 | Xq21.1 | |
| Type of gene | protein-coding | protein-coding | |
| Description | 60S ribosomal protein L15large ribosomal subunit protein eL15 | phosphoglycerate kinase 1PRP 2cell migration-inducing gene 10 proteinepididymis secretory sperm binding protein Li 68pprimer recognition protein 2 | |
| Modification date | 20200313 | 20200313 | |
| UniProtAcc | . | . | |
| Ensembl transtripts involved in fusion gene | ENST00000369817, ENST00000479366, ENST00000424325, ENST00000406022, | ENST00000373316, ENST00000442431, ENST00000537456, ENST00000476531, | |
| Fusion gene scores | * DoF score | 11 X 12 X 7=924 | 13 X 12 X 6=936 |
| # samples | 17 | 14 | |
| ** MAII score | log2(17/924*10)=-2.44235810527836 possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs). DoF>8 and MAII<0 | log2(14/936*10)=-2.74108170263844 possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs). DoF>8 and MAII<0 | |
| Context | PubMed: RPL10 [Title/Abstract] AND PGK1 [Title/Abstract] AND fusion [Title/Abstract] | ||
| Most frequent breakpoint | RPL10(153628282)-PGK1(77369512), # samples:1 | ||
| Anticipated loss of major functional domain due to fusion event. | |||
| * DoF score (Degree of Frequency) = # partners X # break points X # cancer types ** MAII score (Major Active Isofusion Index) = log2(# samples/DoF score*10) |
| Gene ontology of each fusion partner gene with evidence of Inferred from Direct Assay (IDA) from Entrez |
| Partner | Gene | GO ID | GO term | PubMed ID |
| Tgene | PGK1 | GO:0071456 | cellular response to hypoxia | 11130727 |
| Fusion gene breakpoints across RPL10 (5'-gene) * Click on the image to open the UCSC genome browser with custom track showing this image in a new window. |
| Fusion gene breakpoints across PGK1 (3'-gene) * Click on the image to open the UCSC genome browser with custom track showing this image in a new window. |
| Fusion gene information from two resources (ChiTars 5.0 and ChimerDB 4.0) * All genome coordinats were lifted-over on hg19. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
| Source | Disease | Sample | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
| ChimerDB4 | Non-Cancer | TCGA-HU-A4G3-11A | RPL10 | chrX | 153628282 | + | PGK1 | chrX | 77369512 | + |
Top |
Fusion Gene ORF analysis for RPL10-PGK1 |
| Open reading frame (ORF) analsis of fusion genes based on Ensembl gene isoform structure. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
| ORF | Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
| In-frame | ENST00000369817 | ENST00000373316 | RPL10 | chrX | 153628282 | + | PGK1 | chrX | 77369512 | + |
| 5CDS-intron | ENST00000369817 | ENST00000442431 | RPL10 | chrX | 153628282 | + | PGK1 | chrX | 77369512 | + |
| 5CDS-intron | ENST00000369817 | ENST00000537456 | RPL10 | chrX | 153628282 | + | PGK1 | chrX | 77369512 | + |
| 5CDS-intron | ENST00000369817 | ENST00000476531 | RPL10 | chrX | 153628282 | + | PGK1 | chrX | 77369512 | + |
| intron-3CDS | ENST00000479366 | ENST00000373316 | RPL10 | chrX | 153628282 | + | PGK1 | chrX | 77369512 | + |
| intron-intron | ENST00000479366 | ENST00000442431 | RPL10 | chrX | 153628282 | + | PGK1 | chrX | 77369512 | + |
| intron-intron | ENST00000479366 | ENST00000537456 | RPL10 | chrX | 153628282 | + | PGK1 | chrX | 77369512 | + |
| intron-intron | ENST00000479366 | ENST00000476531 | RPL10 | chrX | 153628282 | + | PGK1 | chrX | 77369512 | + |
| In-frame | ENST00000424325 | ENST00000373316 | RPL10 | chrX | 153628282 | + | PGK1 | chrX | 77369512 | + |
| 5CDS-intron | ENST00000424325 | ENST00000442431 | RPL10 | chrX | 153628282 | + | PGK1 | chrX | 77369512 | + |
| 5CDS-intron | ENST00000424325 | ENST00000537456 | RPL10 | chrX | 153628282 | + | PGK1 | chrX | 77369512 | + |
| 5CDS-intron | ENST00000424325 | ENST00000476531 | RPL10 | chrX | 153628282 | + | PGK1 | chrX | 77369512 | + |
| In-frame | ENST00000406022 | ENST00000373316 | RPL10 | chrX | 153628282 | + | PGK1 | chrX | 77369512 | + |
| 5CDS-intron | ENST00000406022 | ENST00000442431 | RPL10 | chrX | 153628282 | + | PGK1 | chrX | 77369512 | + |
| 5CDS-intron | ENST00000406022 | ENST00000537456 | RPL10 | chrX | 153628282 | + | PGK1 | chrX | 77369512 | + |
| 5CDS-intron | ENST00000406022 | ENST00000476531 | RPL10 | chrX | 153628282 | + | PGK1 | chrX | 77369512 | + |
| ORFfinder result based on the fusion transcript sequence of in-frame fusion genes. |
| Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand | Seq length (transcript) | BP loci (transcript) | Predicted start (transcript) | Predicted stop (transcript) | Seq length (amino acids) |
| ENST00000369817 | RPL10 | chrX | 153628282 | + | ENST00000373316 | PGK1 | chrX | 77369512 | + | 5353 | 905 | 441 | 1886 | 481 |
| ENST00000424325 | RPL10 | chrX | 153628282 | + | ENST00000373316 | PGK1 | chrX | 77369512 | + | 4965 | 517 | 53 | 1498 | 481 |
| ENST00000406022 | RPL10 | chrX | 153628282 | + | ENST00000373316 | PGK1 | chrX | 77369512 | + | 4825 | 377 | 153 | 1358 | 401 |
| DeepORF prediction of the coding potential based on the fusion transcript sequence of in-frame fusion genes. DeepORF is a coding potential classifier based on convolutional neural network by comparing the real Ribo-seq data. If the no-coding score < 0.5 and coding score > 0.5, then the in-frame fusion transcript is predicted as being likely translated. |
| Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand | No-coding score | Coding score |
| ENST00000369817 | ENST00000373316 | RPL10 | chrX | 153628282 | + | PGK1 | chrX | 77369512 | + | 0.000270826 | 0.9997292 |
| ENST00000424325 | ENST00000373316 | RPL10 | chrX | 153628282 | + | PGK1 | chrX | 77369512 | + | 0.000271928 | 0.999728 |
| ENST00000406022 | ENST00000373316 | RPL10 | chrX | 153628282 | + | PGK1 | chrX | 77369512 | + | 0.000201482 | 0.9997986 |
Top |
Fusion Genomic Features for RPL10-PGK1 |
| FusionAI prediction of the potential fusion gene breakpoint based on the pre-mature RNA sequence context (+/- 5kb of individual partner genes, total 20kb length sequence). FusionAI is a fusion gene breakpoint classifier based on convolutional neural network by comparing the fusion positive and negative sequence context of ~ 20K fusion gene data. From here, we can have the relative potentency of the 20K genomic sequence how individual sequnce will be likely used as the gene fusion breakpoints. |
| Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand | 1-p | p (fusion gene breakpoint) |
| RPL10 | chrX | 153628282 | + | PGK1 | chrX | 77369512 | + | 4.01E-05 | 0.9999598 |
| RPL10 | chrX | 153628282 | + | PGK1 | chrX | 77369512 | + | 4.01E-05 | 0.9999598 |
| Distribution of 44 human genomic features loci across 20kb length fusion breakpoint regions. We integrated a total of 44 different types of human genomic feature loci information across five big categories including virus integration sites, repeats, structural variants, chromatin states, and gene expression regulation. More details are in help page. |
| Distribution of 44 human genomic features loci across 20kb length fusion breakpoint regions that are ovelapped with the top 1% feature importance score regions. More details are in help page. |
Top |
Fusion Protein Features for RPL10-PGK1 |
| Go to FGviewer for the breakpoints of chrX:153628282-chrX:77369512 - FGviewer provides the online visualization of the retention search of the protein functional features across DNA, RNA, protein, and pathological levels. |
 |
| Main function of each fusion partner protein. (from UniProt) |
| Hgene | Tgene |
| . | . |
| FUNCTION: Might normally function as a transcriptional repressor. EWS-fusion-proteins (EFPS) may play a role in the tumorigenic process. They may disturb gene expression by mimicking, or interfering with the normal function of CTD-POLII within the transcription initiation complex. They may also contribute to an aberrant activation of the fusion protein target genes. | FUNCTION: Might normally function as a transcriptional repressor. EWS-fusion-proteins (EFPS) may play a role in the tumorigenic process. They may disturb gene expression by mimicking, or interfering with the normal function of CTD-POLII within the transcription initiation complex. They may also contribute to an aberrant activation of the fusion protein target genes. |
| Retention analysis result of each fusion partner protein across 39 protein features of UniProt such as six molecule processing features, 13 region features, four site features, six amino acid modification features, two natural variation features, five experimental info features, and 3 secondary structure features. Here, because of limited space for viewing, we only show the protein feature retention information belong to the 13 regional features. All retention annotation result can be downloaded at * Minus value of BPloci means that the break pointn is located before the CDS. |
| - In-frame and retained protein feature among the 13 regional features. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
| Tgene | PGK1 | chrX:153628282 | chrX:77369512 | ENST00000373316 | 2 | 11 | 373_376 | 90.66666666666667 | 418.0 | Nucleotide binding | ATP |
| - In-frame and not-retained protein feature among the 13 regional features. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
| Tgene | PGK1 | chrX:153628282 | chrX:77369512 | ENST00000373316 | 2 | 11 | 24_26 | 90.66666666666667 | 418.0 | Region | Substrate binding | |
| Tgene | PGK1 | chrX:153628282 | chrX:77369512 | ENST00000373316 | 2 | 11 | 63_66 | 90.66666666666667 | 418.0 | Region | Substrate binding |
Top |
Fusion Gene Sequence for RPL10-PGK1 |
| For in-frame fusion transcripts, we provide the fusion transcript sequences and fusion amino acid sequences. To have fusion amino acid sequence, we ran ORFfinder and chose the longest ORF among the all predicted ones. |
| >In-frame_ENST00000369817_ENST00000373316_TCGA-HU-A4G3-11A_RPL10_chrX_153628282_+_PGK1_chrX_77369512_length(transcript)=5353nt_BP=905nt GCAATTCCTGACTTGTACTGCCCCAGTGGTGTTACAGCCTCGAACCCAGTTTCCAGACCTAAGTCACCGCCGGCATCCAGAGTCCCATGA TGGAAAGGGAGGCTAGGTTCCCCTGGGAAGGACCTTGCACCACTGCTGCAAGTGCACCCCAGAAATCGTCCCAAGCTTTTCTCAAAGGGA CCTGCAGCCATTTATAAAAGCGACATATCATCCTGGAAAACAGAAATATACGTCTGTCACAGTTAACGGCAAAGCCTAGGGCAAGAGTTC TACGCCCAAGATGGCCAGCCGGAAGCGGGCTTCTCGCGACCATGTGGCGAAGCCCCATTCGTCAGCTGGCCGCCCGCGGCCCTGGTACCC GGTCACCTCTCTGATCTGCGCATGTGCTGGGCTACGCCCGGGCGCAAGCGCCAAGAGCGGCTGCGTCTATGGTCATGACGTCTGACAGAG CGTCCACCCGTCTTCGACAGGACTCTATGGTTCTTACGCGCGCAGACAGACCGCCTATATAAGCCATGCGCAGGCGGAGGAGCGCCTCTT TCCCTTCGGTGTGCCACTGAAGATCCTGGTGTCGCCATGGGCCGCCGCCCCGCCCGTTGTTACCGGTATTGTAAGAACAAGCCGTACCCA AAGTCTCGCTTCTGCCGAGGTGTCCCTGATGCCAAGATTCGCATTTTTGACCTGGGGCGGAAAAAGGCAAAAGTGGATGAGTTTCCGCTT TGTGGCCACATGGTGTCAGATGAATATGAGCAGCTGTCCTCTGAAGCCCTGGAGGCTGCCCGAATTTGTGCCAATAAGTACATGGTAAAA AGTTGTGGCAAAGATGGCTTCCATATCCGGGTGCGGCTCCACCCCTTCCACGTCATCCGCATCAACAAGATGTTGTCCTGTGCTGGGGCT GACAGGGATGTTCTGTTCTTGAAGGACTGTGTAGGCCCAGAAGTGGAGAAAGCCTGTGCCAACCCAGCTGCTGGGTCTGTCATCCTGCTG GAGAACCTCCGCTTTCATGTGGAGGAAGAAGGGAAGGGAAAAGATGCTTCTGGGAACAAGGTTAAAGCCGAGCCAGCCAAAATAGAAGCT TTCCGAGCTTCACTTTCCAAGCTAGGGGATGTCTATGTCAATGATGCTTTTGGCACTGCTCACAGAGCCCACAGCTCCATGGTAGGAGTC AATCTGCCACAGAAGGCTGGTGGGTTTTTGATGAAGAAGGAGCTGAACTACTTTGCAAAGGCCTTGGAGAGCCCAGAGCGACCCTTCCTG GCCATCCTGGGCGGAGCTAAAGTTGCAGACAAGATCCAGCTCATCAATAATATGCTGGACAAAGTCAATGAGATGATTATTGGTGGTGGA ATGGCTTTTACCTTCCTTAAGGTGCTCAACAACATGGAGATTGGCACTTCTCTGTTTGATGAAGAGGGAGCCAAGATTGTCAAAGACCTA ATGTCCAAAGCTGAGAAGAATGGTGTGAAGATTACCTTGCCTGTTGACTTTGTCACTGCTGACAAGTTTGATGAGAATGCCAAGACTGGC CAAGCCACTGTGGCTTCTGGCATACCTGCTGGCTGGATGGGCTTGGACTGTGGTCCTGAAAGCAGCAAGAAGTATGCTGAGGCTGTCACT CGGGCTAAGCAGATTGTGTGGAATGGTCCTGTGGGGGTATTTGAATGGGAAGCTTTTGCCCGGGGAACCAAAGCTCTCATGGATGAGGTG GTGAAAGCCACTTCTAGGGGCTGCATCACCATCATAGGTGGTGGAGACACTGCCACTTGCTGTGCCAAATGGAACACGGAGGATAAAGTC AGCCATGTGAGCACTGGGGGTGGTGCCAGTTTGGAGCTCCTGGAAGGTAAAGTCCTTCCTGGGGTGGATGCTCTCAGCAATATTTAGTAC TTTCCTGCCTTTTAGTTCCTGTGCACAGCCCCTAAGTCAACTTAGCATTTTCTGCATCTCCACTTGGCATTAGCTAAAACCTTCCATGTC AAGATTCAGCTAGTGGCCAAGAGATGCAGTGCCAGGAACCCTTAAACAGTTGCACAGCATCTCAGCTCATCTTCACTGCACCCTGGATTT GCATACATTCTTCAAGATCCCATTTGAATTTTTTAGTGACTAAACCATTGTGCATTCTAGAGTGCATATATTTATATTTTGCCTGTTAAA AAGAAAGTGAGCAGTGTTAGCTTAGTTCTCTTTTGATGTAGGTTATTATGATTAGCTTTGTCACTGTTTCACTACTCAGCATGGAAACAA GATGAAATTCCATTTGTAGGTAGTGAGACAAAATTGATGATCCATTAAGTAAACAATAAAAGTGTCCATTGAAACCGTGATTTTTTTTTT TTTCCTGTCATACTTTGTTAGGAAGGGTGAGAATAGAATCTTGAGGAACGGATCAGATGTCTATATTGCTGAATGCAAGAAGTGGGGCAG CAGCAGTGGAGAGATGGGACAATTAGATAAATGTCCATTCTTTATCAAGGGCCTACTTTATGGCAGACATTGTGCTAGTGCTTTTATTCT AACTTTTATTTTTATCAGTTACACATGATCATAATTTAAAAAGTCAAGGCTTATAACAAAAAAGCCCCAGCCCATTCCTCCCATTCAAGA TTCCCACTCCCCAGAGGTGACCACTTTCAACTCTTGAGTTTTTCAGGTATATACCTCCATGTTTCTAAGTAATATGCTTATATTGTTCAC TTCTTTTTTTTTTATTTTTTAAAGAAATCTATTTCATACCATGGAGGAAGGCTCTGTTCCACATATATTTCCACTTCTTCATTCTCTCGG TATAGTTTTGTCACAATTATAGATTAGATCAAAAGTCTACATAACTAATACAGCTGAGCTATGTAGTATGCTATGATTAAATTTACTTAT GTAACTTTTATTGTCTTTGGCATTAACAGTGTTTCAAAAAATTTTCTGTGTATACCCATCAGTGATTCATTCCCAAATCTTCTAGAAGCA TAAGTGTCTCAATATATTAAAACATATTGAATAATCCTTGTTAGAGTTATCCCTGCAGGAGTCCTTAGTGCTCCTTTATCCAATTTGTAC TTGATGCCCTCTAGGCAGGGTGTACAGCTAGCTGTTGCTCTGGTATTTCCTATAACCTTCTTGGGGATTTCTTTTACCTCCTGTGTTAGA CTCCTGTTTTCTGGATTCCCCCTTTTCCCTCTTTCTTGGTCTACTTTTTGTAGAACACAAGACTCTACTAGCTTCCTGAGAAAGGGTGCC TGGGAGGCAAAATCTCTAAGACTTTGTAAGTCTGAAAATGTCTTTATTCGACCCTTATACTTGATTCCTAGTTTGGCTATATATAGAATT TTAGCCTGAGTATCACTTTTTGAGACTCGAAGCCACTGTTTCATTGTCACTATTGAGAATCTAAATGGCCATTCGGATTCTTTCATCATC TTTATAATTTTACCTTCCTATTTCTTTCCTGTCCTTTTAATGGAGTTTTGGGAGAGAGCAGAGGTAAACATGATTTGAAAAAGCCATGTC TGACCAGAAATTCTGTGCTGGAAAGATATGTATTTCACCTTTAGGGACAAAGAAATAAACTTTTGGACAGGACCACAGAGCTAGTAAGTA ACAGCAGGGATTCAAGTCCAGGTTTGTCTGGTTCCAGTGGCTGATGCTTTTCCAATGTGCCTCCGTCCCTGACATGATGCTTCTAGGCTA TAGATGCTTCTAGACTCTATCCCTGACATGATGCTTCTAGACTATTTTGTTTAACCCTGGATAGAATAGCAAAAGAAAATTTTGGTGGTT GCTCTAAACAAAACAGAAATTTGAAAGCTCAAGTTTTTTCTTCATTTGTATTTTAGTTAATACTGTACCCATATTTGTAGTTAATTTTAA ATTGTACCATGTTTCTGCATACCTCTATGGGTACTCAGGAATTCTAGTCCAATTTTTGTGACTTTTTCCTACTGATTACCTTTCCTCCAA CGTTTTAAAAATTATTTCAAATGGAACTGAAAGAAGCATAAACTCCCATAAACCCAGCACCTAGACTCTACAATTGCCAACATTATCTAT CCAACAATCTCTGACTGTACCTTTTAAGTACTTTCTACTGGACTGTTTCCAGGATCACCCCTCATTTATTTGGGTTGTTAACCTAAAGAA TGAATGGGGGAATCTCCAGTCATAAACAACTTGTCAATTAGGCAAATATTTGAGTTCCTTCTATGTGCTTAAAGACGTGATAGAGGGAAT ATAAGAGCATTTATGTTCTGAAGGAATTTTTAACCTAACCAAAGAAGATAGTAGATAACTTGTGTGCATATAAGCTAGAACAGTATAAGG GGCCGGGCATGGTGGCTTACGCCTGTAATCCCAGGACTTTGGGAGGCCAAGGCGGGCAGATCACCTGTCAGGAGTTTGGGACCAGCCTGG CCAACATGGTGAAACCCCGTTTCTACCAAAAATACAAAAATTAGCCGGGCGTGGTGGCGTGTGCCACTGTAGTCCCAGCTATTCAGAAGG CTGAGGCAGGAGAATCACTTGAACCCGGGAGGTGGAGGTTGCAGTGAGCTGAGATCACGCTACTGCATTCCTGCTTGGGCGACAGAGTGA GACTCTGCCTCAAAACAAAAACCCCACAAAACAGTATAAGGATGTGCTTTCTAATTTGGAATTATGAATTATTGGTAAAATATTGCAAAG GTGTATGCTTTAAGTTGTAAATTCACCTTTAACCCTAGACTATATATGTGTGTTTATATGCAGAAAAAAATAATTCCCATGTCGTAAGTG AACAATTTGGTTCTTTAGCTCAGTGTTTTCCTGTTTTCTTCATTTCCAAAATTTCCCTCTAGCACAGGGGTTTACACATGATCAAAAAGG AGTATACAATGAAGACACCTTCCTCAGTCCCCTACCTACCAGTTTCCCTCCCCAGAAGCAACCTCTGGAAGACCAGTTTCTTTCAATCTA AGGCTATTTAATATACATTAAGAGGCCGGGCGCAGTGGCTCACGCCTGTAATCCCAACAACACTTTGGGAGGCCCAGGCAGGCGGGTCAT GAGGTCAGGAGATTGAGACCATCCTGGCTAACACGGTGAAACCCTGTCTCTACTAAAAATACAAAAAATTAGCTGGGCGTGATGGTGGGC GCCTGTAGTCCCAGCTACTCGGGAGGCTGAGGCAGGAGAATGGCGTGAACCTGGGAAGCGGAGCTCGCAGTGAGCCGAGATCACGCCACT GCACTCCAGCCTGGGCAACAGTGAGACTCTGCATAAAGAGCATACCCATGTGTGTACCTATCTATCTATCTATCTATCTATCTATCTATC >In-frame_ENST00000369817_ENST00000373316_TCGA-HU-A4G3-11A_RPL10_chrX_153628282_+_PGK1_chrX_77369512_length(amino acids)=481AA_start in transcript=441_stop in transcript=1886 MTERPPVFDRTLWFLRAQTDRLYKPCAGGGAPLSLRCATEDPGVAMGRRPARCYRYCKNKPYPKSRFCRGVPDAKIRIFDLGRKKAKVDE FPLCGHMVSDEYEQLSSEALEAARICANKYMVKSCGKDGFHIRVRLHPFHVIRINKMLSCAGADRDVLFLKDCVGPEVEKACANPAAGSV ILLENLRFHVEEEGKGKDASGNKVKAEPAKIEAFRASLSKLGDVYVNDAFGTAHRAHSSMVGVNLPQKAGGFLMKKELNYFAKALESPER PFLAILGGAKVADKIQLINNMLDKVNEMIIGGGMAFTFLKVLNNMEIGTSLFDEEGAKIVKDLMSKAEKNGVKITLPVDFVTADKFDENA KTGQATVASGIPAGWMGLDCGPESSKKYAEAVTRAKQIVWNGPVGVFEWEAFARGTKALMDEVVKATSRGCITIIGGGDTATCCAKWNTE -------------------------------------------------------------- >In-frame_ENST00000424325_ENST00000373316_TCGA-HU-A4G3-11A_RPL10_chrX_153628282_+_PGK1_chrX_77369512_length(transcript)=4965nt_BP=517nt GGGCTACGCCCGGGCGCAAGCGCCAAGAGCGGCTGCGTCTATGGTCATGACGTCTGACAGAGCGTCCACCCGTCTTCGACAGGACTCTAT GGTTCTTACGCGCGCAGACAGACCGCCTATATAAGCCATGCGCAGGCGGAGGAGCGCCTCTTTCCCTTCGGTGTGCCACTGAAGATCCTG GTGTCGCCATGGGCCGCCGCCCCGCCCGTTGTTACCGGTATTGTAAGAACAAGCCGTACCCAAAGTCTCGCTTCTGCCGAGGTGTCCCTG ATGCCAAGATTCGCATTTTTGACCTGGGGCGGAAAAAGGCAAAAGTGGATGAGTTTCCGCTTTGTGGCCACATGGTGTCAGATGAATATG AGCAGCTGTCCTCTGAAGCCCTGGAGGCTGCCCGAATTTGTGCCAATAAGTACATGGTAAAAAGTTGTGGCAAAGATGGCTTCCATATCC GGGTGCGGCTCCACCCCTTCCACGTCATCCGCATCAACAAGATGTTGTCCTGTGCTGGGGCTGACAGGGATGTTCTGTTCTTGAAGGACT GTGTAGGCCCAGAAGTGGAGAAAGCCTGTGCCAACCCAGCTGCTGGGTCTGTCATCCTGCTGGAGAACCTCCGCTTTCATGTGGAGGAAG AAGGGAAGGGAAAAGATGCTTCTGGGAACAAGGTTAAAGCCGAGCCAGCCAAAATAGAAGCTTTCCGAGCTTCACTTTCCAAGCTAGGGG ATGTCTATGTCAATGATGCTTTTGGCACTGCTCACAGAGCCCACAGCTCCATGGTAGGAGTCAATCTGCCACAGAAGGCTGGTGGGTTTT TGATGAAGAAGGAGCTGAACTACTTTGCAAAGGCCTTGGAGAGCCCAGAGCGACCCTTCCTGGCCATCCTGGGCGGAGCTAAAGTTGCAG ACAAGATCCAGCTCATCAATAATATGCTGGACAAAGTCAATGAGATGATTATTGGTGGTGGAATGGCTTTTACCTTCCTTAAGGTGCTCA ACAACATGGAGATTGGCACTTCTCTGTTTGATGAAGAGGGAGCCAAGATTGTCAAAGACCTAATGTCCAAAGCTGAGAAGAATGGTGTGA AGATTACCTTGCCTGTTGACTTTGTCACTGCTGACAAGTTTGATGAGAATGCCAAGACTGGCCAAGCCACTGTGGCTTCTGGCATACCTG CTGGCTGGATGGGCTTGGACTGTGGTCCTGAAAGCAGCAAGAAGTATGCTGAGGCTGTCACTCGGGCTAAGCAGATTGTGTGGAATGGTC CTGTGGGGGTATTTGAATGGGAAGCTTTTGCCCGGGGAACCAAAGCTCTCATGGATGAGGTGGTGAAAGCCACTTCTAGGGGCTGCATCA CCATCATAGGTGGTGGAGACACTGCCACTTGCTGTGCCAAATGGAACACGGAGGATAAAGTCAGCCATGTGAGCACTGGGGGTGGTGCCA GTTTGGAGCTCCTGGAAGGTAAAGTCCTTCCTGGGGTGGATGCTCTCAGCAATATTTAGTACTTTCCTGCCTTTTAGTTCCTGTGCACAG CCCCTAAGTCAACTTAGCATTTTCTGCATCTCCACTTGGCATTAGCTAAAACCTTCCATGTCAAGATTCAGCTAGTGGCCAAGAGATGCA GTGCCAGGAACCCTTAAACAGTTGCACAGCATCTCAGCTCATCTTCACTGCACCCTGGATTTGCATACATTCTTCAAGATCCCATTTGAA TTTTTTAGTGACTAAACCATTGTGCATTCTAGAGTGCATATATTTATATTTTGCCTGTTAAAAAGAAAGTGAGCAGTGTTAGCTTAGTTC TCTTTTGATGTAGGTTATTATGATTAGCTTTGTCACTGTTTCACTACTCAGCATGGAAACAAGATGAAATTCCATTTGTAGGTAGTGAGA CAAAATTGATGATCCATTAAGTAAACAATAAAAGTGTCCATTGAAACCGTGATTTTTTTTTTTTTCCTGTCATACTTTGTTAGGAAGGGT GAGAATAGAATCTTGAGGAACGGATCAGATGTCTATATTGCTGAATGCAAGAAGTGGGGCAGCAGCAGTGGAGAGATGGGACAATTAGAT AAATGTCCATTCTTTATCAAGGGCCTACTTTATGGCAGACATTGTGCTAGTGCTTTTATTCTAACTTTTATTTTTATCAGTTACACATGA TCATAATTTAAAAAGTCAAGGCTTATAACAAAAAAGCCCCAGCCCATTCCTCCCATTCAAGATTCCCACTCCCCAGAGGTGACCACTTTC AACTCTTGAGTTTTTCAGGTATATACCTCCATGTTTCTAAGTAATATGCTTATATTGTTCACTTCTTTTTTTTTTATTTTTTAAAGAAAT CTATTTCATACCATGGAGGAAGGCTCTGTTCCACATATATTTCCACTTCTTCATTCTCTCGGTATAGTTTTGTCACAATTATAGATTAGA TCAAAAGTCTACATAACTAATACAGCTGAGCTATGTAGTATGCTATGATTAAATTTACTTATGTAACTTTTATTGTCTTTGGCATTAACA GTGTTTCAAAAAATTTTCTGTGTATACCCATCAGTGATTCATTCCCAAATCTTCTAGAAGCATAAGTGTCTCAATATATTAAAACATATT GAATAATCCTTGTTAGAGTTATCCCTGCAGGAGTCCTTAGTGCTCCTTTATCCAATTTGTACTTGATGCCCTCTAGGCAGGGTGTACAGC TAGCTGTTGCTCTGGTATTTCCTATAACCTTCTTGGGGATTTCTTTTACCTCCTGTGTTAGACTCCTGTTTTCTGGATTCCCCCTTTTCC CTCTTTCTTGGTCTACTTTTTGTAGAACACAAGACTCTACTAGCTTCCTGAGAAAGGGTGCCTGGGAGGCAAAATCTCTAAGACTTTGTA AGTCTGAAAATGTCTTTATTCGACCCTTATACTTGATTCCTAGTTTGGCTATATATAGAATTTTAGCCTGAGTATCACTTTTTGAGACTC GAAGCCACTGTTTCATTGTCACTATTGAGAATCTAAATGGCCATTCGGATTCTTTCATCATCTTTATAATTTTACCTTCCTATTTCTTTC CTGTCCTTTTAATGGAGTTTTGGGAGAGAGCAGAGGTAAACATGATTTGAAAAAGCCATGTCTGACCAGAAATTCTGTGCTGGAAAGATA TGTATTTCACCTTTAGGGACAAAGAAATAAACTTTTGGACAGGACCACAGAGCTAGTAAGTAACAGCAGGGATTCAAGTCCAGGTTTGTC TGGTTCCAGTGGCTGATGCTTTTCCAATGTGCCTCCGTCCCTGACATGATGCTTCTAGGCTATAGATGCTTCTAGACTCTATCCCTGACA TGATGCTTCTAGACTATTTTGTTTAACCCTGGATAGAATAGCAAAAGAAAATTTTGGTGGTTGCTCTAAACAAAACAGAAATTTGAAAGC TCAAGTTTTTTCTTCATTTGTATTTTAGTTAATACTGTACCCATATTTGTAGTTAATTTTAAATTGTACCATGTTTCTGCATACCTCTAT GGGTACTCAGGAATTCTAGTCCAATTTTTGTGACTTTTTCCTACTGATTACCTTTCCTCCAACGTTTTAAAAATTATTTCAAATGGAACT GAAAGAAGCATAAACTCCCATAAACCCAGCACCTAGACTCTACAATTGCCAACATTATCTATCCAACAATCTCTGACTGTACCTTTTAAG TACTTTCTACTGGACTGTTTCCAGGATCACCCCTCATTTATTTGGGTTGTTAACCTAAAGAATGAATGGGGGAATCTCCAGTCATAAACA ACTTGTCAATTAGGCAAATATTTGAGTTCCTTCTATGTGCTTAAAGACGTGATAGAGGGAATATAAGAGCATTTATGTTCTGAAGGAATT TTTAACCTAACCAAAGAAGATAGTAGATAACTTGTGTGCATATAAGCTAGAACAGTATAAGGGGCCGGGCATGGTGGCTTACGCCTGTAA TCCCAGGACTTTGGGAGGCCAAGGCGGGCAGATCACCTGTCAGGAGTTTGGGACCAGCCTGGCCAACATGGTGAAACCCCGTTTCTACCA AAAATACAAAAATTAGCCGGGCGTGGTGGCGTGTGCCACTGTAGTCCCAGCTATTCAGAAGGCTGAGGCAGGAGAATCACTTGAACCCGG GAGGTGGAGGTTGCAGTGAGCTGAGATCACGCTACTGCATTCCTGCTTGGGCGACAGAGTGAGACTCTGCCTCAAAACAAAAACCCCACA AAACAGTATAAGGATGTGCTTTCTAATTTGGAATTATGAATTATTGGTAAAATATTGCAAAGGTGTATGCTTTAAGTTGTAAATTCACCT TTAACCCTAGACTATATATGTGTGTTTATATGCAGAAAAAAATAATTCCCATGTCGTAAGTGAACAATTTGGTTCTTTAGCTCAGTGTTT TCCTGTTTTCTTCATTTCCAAAATTTCCCTCTAGCACAGGGGTTTACACATGATCAAAAAGGAGTATACAATGAAGACACCTTCCTCAGT CCCCTACCTACCAGTTTCCCTCCCCAGAAGCAACCTCTGGAAGACCAGTTTCTTTCAATCTAAGGCTATTTAATATACATTAAGAGGCCG GGCGCAGTGGCTCACGCCTGTAATCCCAACAACACTTTGGGAGGCCCAGGCAGGCGGGTCATGAGGTCAGGAGATTGAGACCATCCTGGC TAACACGGTGAAACCCTGTCTCTACTAAAAATACAAAAAATTAGCTGGGCGTGATGGTGGGCGCCTGTAGTCCCAGCTACTCGGGAGGCT GAGGCAGGAGAATGGCGTGAACCTGGGAAGCGGAGCTCGCAGTGAGCCGAGATCACGCCACTGCACTCCAGCCTGGGCAACAGTGAGACT CTGCATAAAGAGCATACCCATGTGTGTACCTATCTATCTATCTATCTATCTATCTATCTATCTATCTATCTGTATATAGATATATTAAAA >In-frame_ENST00000424325_ENST00000373316_TCGA-HU-A4G3-11A_RPL10_chrX_153628282_+_PGK1_chrX_77369512_length(amino acids)=481AA_start in transcript=53_stop in transcript=1498 MTERPPVFDRTLWFLRAQTDRLYKPCAGGGAPLSLRCATEDPGVAMGRRPARCYRYCKNKPYPKSRFCRGVPDAKIRIFDLGRKKAKVDE FPLCGHMVSDEYEQLSSEALEAARICANKYMVKSCGKDGFHIRVRLHPFHVIRINKMLSCAGADRDVLFLKDCVGPEVEKACANPAAGSV ILLENLRFHVEEEGKGKDASGNKVKAEPAKIEAFRASLSKLGDVYVNDAFGTAHRAHSSMVGVNLPQKAGGFLMKKELNYFAKALESPER PFLAILGGAKVADKIQLINNMLDKVNEMIIGGGMAFTFLKVLNNMEIGTSLFDEEGAKIVKDLMSKAEKNGVKITLPVDFVTADKFDENA KTGQATVASGIPAGWMGLDCGPESSKKYAEAVTRAKQIVWNGPVGVFEWEAFARGTKALMDEVVKATSRGCITIIGGGDTATCCAKWNTE -------------------------------------------------------------- >In-frame_ENST00000406022_ENST00000373316_TCGA-HU-A4G3-11A_RPL10_chrX_153628282_+_PGK1_chrX_77369512_length(transcript)=4825nt_BP=377nt CGGGAAAAACGGGTGCGGCCGCCTCCTGTGTCCTACAGGGGGCGCCAGACGCATTTCCACTCGGCTTGGAGTTACCGGTATTGTAAGAAC AAGCCGTACCCAAAGTCTCGCTTCTGCCGAGGTGTCCCTGATGCCAAGATTCGCATTTTTGACCTGGGGCGGAAAAAGGCAAAAGTGGAT GAGTTTCCGCTTTGTGGCCACATGGTGTCAGATGAATATGAGCAGCTGTCCTCTGAAGCCCTGGAGGCTGCCCGAATTTGTGCCAATAAG TACATGGTAAAAAGTTGTGGCAAAGATGGCTTCCATATCCGGGTGCGGCTCCACCCCTTCCACGTCATCCGCATCAACAAGATGTTGTCC TGTGCTGGGGCTGACAGGGATGTTCTGTTCTTGAAGGACTGTGTAGGCCCAGAAGTGGAGAAAGCCTGTGCCAACCCAGCTGCTGGGTCT GTCATCCTGCTGGAGAACCTCCGCTTTCATGTGGAGGAAGAAGGGAAGGGAAAAGATGCTTCTGGGAACAAGGTTAAAGCCGAGCCAGCC AAAATAGAAGCTTTCCGAGCTTCACTTTCCAAGCTAGGGGATGTCTATGTCAATGATGCTTTTGGCACTGCTCACAGAGCCCACAGCTCC ATGGTAGGAGTCAATCTGCCACAGAAGGCTGGTGGGTTTTTGATGAAGAAGGAGCTGAACTACTTTGCAAAGGCCTTGGAGAGCCCAGAG CGACCCTTCCTGGCCATCCTGGGCGGAGCTAAAGTTGCAGACAAGATCCAGCTCATCAATAATATGCTGGACAAAGTCAATGAGATGATT ATTGGTGGTGGAATGGCTTTTACCTTCCTTAAGGTGCTCAACAACATGGAGATTGGCACTTCTCTGTTTGATGAAGAGGGAGCCAAGATT GTCAAAGACCTAATGTCCAAAGCTGAGAAGAATGGTGTGAAGATTACCTTGCCTGTTGACTTTGTCACTGCTGACAAGTTTGATGAGAAT GCCAAGACTGGCCAAGCCACTGTGGCTTCTGGCATACCTGCTGGCTGGATGGGCTTGGACTGTGGTCCTGAAAGCAGCAAGAAGTATGCT GAGGCTGTCACTCGGGCTAAGCAGATTGTGTGGAATGGTCCTGTGGGGGTATTTGAATGGGAAGCTTTTGCCCGGGGAACCAAAGCTCTC ATGGATGAGGTGGTGAAAGCCACTTCTAGGGGCTGCATCACCATCATAGGTGGTGGAGACACTGCCACTTGCTGTGCCAAATGGAACACG GAGGATAAAGTCAGCCATGTGAGCACTGGGGGTGGTGCCAGTTTGGAGCTCCTGGAAGGTAAAGTCCTTCCTGGGGTGGATGCTCTCAGC AATATTTAGTACTTTCCTGCCTTTTAGTTCCTGTGCACAGCCCCTAAGTCAACTTAGCATTTTCTGCATCTCCACTTGGCATTAGCTAAA ACCTTCCATGTCAAGATTCAGCTAGTGGCCAAGAGATGCAGTGCCAGGAACCCTTAAACAGTTGCACAGCATCTCAGCTCATCTTCACTG CACCCTGGATTTGCATACATTCTTCAAGATCCCATTTGAATTTTTTAGTGACTAAACCATTGTGCATTCTAGAGTGCATATATTTATATT TTGCCTGTTAAAAAGAAAGTGAGCAGTGTTAGCTTAGTTCTCTTTTGATGTAGGTTATTATGATTAGCTTTGTCACTGTTTCACTACTCA GCATGGAAACAAGATGAAATTCCATTTGTAGGTAGTGAGACAAAATTGATGATCCATTAAGTAAACAATAAAAGTGTCCATTGAAACCGT GATTTTTTTTTTTTTCCTGTCATACTTTGTTAGGAAGGGTGAGAATAGAATCTTGAGGAACGGATCAGATGTCTATATTGCTGAATGCAA GAAGTGGGGCAGCAGCAGTGGAGAGATGGGACAATTAGATAAATGTCCATTCTTTATCAAGGGCCTACTTTATGGCAGACATTGTGCTAG TGCTTTTATTCTAACTTTTATTTTTATCAGTTACACATGATCATAATTTAAAAAGTCAAGGCTTATAACAAAAAAGCCCCAGCCCATTCC TCCCATTCAAGATTCCCACTCCCCAGAGGTGACCACTTTCAACTCTTGAGTTTTTCAGGTATATACCTCCATGTTTCTAAGTAATATGCT TATATTGTTCACTTCTTTTTTTTTTATTTTTTAAAGAAATCTATTTCATACCATGGAGGAAGGCTCTGTTCCACATATATTTCCACTTCT TCATTCTCTCGGTATAGTTTTGTCACAATTATAGATTAGATCAAAAGTCTACATAACTAATACAGCTGAGCTATGTAGTATGCTATGATT AAATTTACTTATGTAACTTTTATTGTCTTTGGCATTAACAGTGTTTCAAAAAATTTTCTGTGTATACCCATCAGTGATTCATTCCCAAAT CTTCTAGAAGCATAAGTGTCTCAATATATTAAAACATATTGAATAATCCTTGTTAGAGTTATCCCTGCAGGAGTCCTTAGTGCTCCTTTA TCCAATTTGTACTTGATGCCCTCTAGGCAGGGTGTACAGCTAGCTGTTGCTCTGGTATTTCCTATAACCTTCTTGGGGATTTCTTTTACC TCCTGTGTTAGACTCCTGTTTTCTGGATTCCCCCTTTTCCCTCTTTCTTGGTCTACTTTTTGTAGAACACAAGACTCTACTAGCTTCCTG AGAAAGGGTGCCTGGGAGGCAAAATCTCTAAGACTTTGTAAGTCTGAAAATGTCTTTATTCGACCCTTATACTTGATTCCTAGTTTGGCT ATATATAGAATTTTAGCCTGAGTATCACTTTTTGAGACTCGAAGCCACTGTTTCATTGTCACTATTGAGAATCTAAATGGCCATTCGGAT TCTTTCATCATCTTTATAATTTTACCTTCCTATTTCTTTCCTGTCCTTTTAATGGAGTTTTGGGAGAGAGCAGAGGTAAACATGATTTGA AAAAGCCATGTCTGACCAGAAATTCTGTGCTGGAAAGATATGTATTTCACCTTTAGGGACAAAGAAATAAACTTTTGGACAGGACCACAG AGCTAGTAAGTAACAGCAGGGATTCAAGTCCAGGTTTGTCTGGTTCCAGTGGCTGATGCTTTTCCAATGTGCCTCCGTCCCTGACATGAT GCTTCTAGGCTATAGATGCTTCTAGACTCTATCCCTGACATGATGCTTCTAGACTATTTTGTTTAACCCTGGATAGAATAGCAAAAGAAA ATTTTGGTGGTTGCTCTAAACAAAACAGAAATTTGAAAGCTCAAGTTTTTTCTTCATTTGTATTTTAGTTAATACTGTACCCATATTTGT AGTTAATTTTAAATTGTACCATGTTTCTGCATACCTCTATGGGTACTCAGGAATTCTAGTCCAATTTTTGTGACTTTTTCCTACTGATTA CCTTTCCTCCAACGTTTTAAAAATTATTTCAAATGGAACTGAAAGAAGCATAAACTCCCATAAACCCAGCACCTAGACTCTACAATTGCC AACATTATCTATCCAACAATCTCTGACTGTACCTTTTAAGTACTTTCTACTGGACTGTTTCCAGGATCACCCCTCATTTATTTGGGTTGT TAACCTAAAGAATGAATGGGGGAATCTCCAGTCATAAACAACTTGTCAATTAGGCAAATATTTGAGTTCCTTCTATGTGCTTAAAGACGT GATAGAGGGAATATAAGAGCATTTATGTTCTGAAGGAATTTTTAACCTAACCAAAGAAGATAGTAGATAACTTGTGTGCATATAAGCTAG AACAGTATAAGGGGCCGGGCATGGTGGCTTACGCCTGTAATCCCAGGACTTTGGGAGGCCAAGGCGGGCAGATCACCTGTCAGGAGTTTG GGACCAGCCTGGCCAACATGGTGAAACCCCGTTTCTACCAAAAATACAAAAATTAGCCGGGCGTGGTGGCGTGTGCCACTGTAGTCCCAG CTATTCAGAAGGCTGAGGCAGGAGAATCACTTGAACCCGGGAGGTGGAGGTTGCAGTGAGCTGAGATCACGCTACTGCATTCCTGCTTGG GCGACAGAGTGAGACTCTGCCTCAAAACAAAAACCCCACAAAACAGTATAAGGATGTGCTTTCTAATTTGGAATTATGAATTATTGGTAA AATATTGCAAAGGTGTATGCTTTAAGTTGTAAATTCACCTTTAACCCTAGACTATATATGTGTGTTTATATGCAGAAAAAAATAATTCCC ATGTCGTAAGTGAACAATTTGGTTCTTTAGCTCAGTGTTTTCCTGTTTTCTTCATTTCCAAAATTTCCCTCTAGCACAGGGGTTTACACA TGATCAAAAAGGAGTATACAATGAAGACACCTTCCTCAGTCCCCTACCTACCAGTTTCCCTCCCCAGAAGCAACCTCTGGAAGACCAGTT TCTTTCAATCTAAGGCTATTTAATATACATTAAGAGGCCGGGCGCAGTGGCTCACGCCTGTAATCCCAACAACACTTTGGGAGGCCCAGG CAGGCGGGTCATGAGGTCAGGAGATTGAGACCATCCTGGCTAACACGGTGAAACCCTGTCTCTACTAAAAATACAAAAAATTAGCTGGGC GTGATGGTGGGCGCCTGTAGTCCCAGCTACTCGGGAGGCTGAGGCAGGAGAATGGCGTGAACCTGGGAAGCGGAGCTCGCAGTGAGCCGA GATCACGCCACTGCACTCCAGCCTGGGCAACAGTGAGACTCTGCATAAAGAGCATACCCATGTGTGTACCTATCTATCTATCTATCTATC >In-frame_ENST00000406022_ENST00000373316_TCGA-HU-A4G3-11A_RPL10_chrX_153628282_+_PGK1_chrX_77369512_length(amino acids)=401AA_start in transcript=153_stop in transcript=1358 MGRKKAKVDEFPLCGHMVSDEYEQLSSEALEAARICANKYMVKSCGKDGFHIRVRLHPFHVIRINKMLSCAGADRDVLFLKDCVGPEVEK ACANPAAGSVILLENLRFHVEEEGKGKDASGNKVKAEPAKIEAFRASLSKLGDVYVNDAFGTAHRAHSSMVGVNLPQKAGGFLMKKELNY FAKALESPERPFLAILGGAKVADKIQLINNMLDKVNEMIIGGGMAFTFLKVLNNMEIGTSLFDEEGAKIVKDLMSKAEKNGVKITLPVDF VTADKFDENAKTGQATVASGIPAGWMGLDCGPESSKKYAEAVTRAKQIVWNGPVGVFEWEAFARGTKALMDEVVKATSRGCITIIGGGDT -------------------------------------------------------------- |
Top |
Fusion Gene PPI Analysis for RPL10-PGK1 |
| Go to ChiPPI (Chimeric Protein-Protein interactions) to see the chimeric PPI interaction in |
| Protein-protein interactors with each fusion partner protein in wild-type (BIOGRID-3.4.160) |
| Hgene | Hgene's interactors | Tgene | Tgene's interactors |
| - Retained PPIs in in-frame fusion. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Still interaction with |
| - Lost PPIs in in-frame fusion. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
| - Retained PPIs, but lost function due to frame-shift fusion. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
Top |
Related Drugs for RPL10-PGK1 |
| Drugs targeting genes involved in this fusion gene. (DrugBank Version 5.1.8 2021-05-08) |
| Partner | Gene | UniProtAcc | DrugBank ID | Drug name | Drug activity | Drug type | Drug status |
Top |
Related Diseases for RPL10-PGK1 |
| Diseases associated with fusion partners. (DisGeNet 4.0) |
| Partner | Gene | Disease ID | Disease name | # pubmeds | Source |
| Hgene | RPL10 | C0796250 | PARTINGTON X-LINKED MENTAL RETARDATION SYNDROME | 6 | CLINGEN |
| Hgene | RPL10 | C3275438 | AUTISM, SUSCEPTIBILITY TO, X-LINKED 5 | 3 | UNIPROT |
| Hgene | RPL10 | C4478383 | MENTAL RETARDATION, X-LINKED, SYNDROMIC, 35 | 3 | GENOMICS_ENGLAND;UNIPROT |
| Hgene | RPL10 | C0004352 | Autistic Disorder | 1 | CTD_human |
| Hgene | RPL10 | C0033578 | Prostatic Neoplasms | 1 | CTD_human |
| Hgene | RPL10 | C0376358 | Malignant neoplasm of prostate | 1 | CTD_human |
| Hgene | RPL10 | C1961099 | Precursor T-Cell Lymphoblastic Leukemia-Lymphoma | 1 | CGI;CTD_human |
| Tgene | PGK1 | C1970848 | Phosphoglycerate Kinase 1 Deficiency | 11 | CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT |
| Tgene | PGK1 | C0007134 | Renal Cell Carcinoma | 1 | CTD_human |
| Tgene | PGK1 | C0279702 | Conventional (Clear Cell) Renal Cell Carcinoma | 1 | CTD_human |
| Tgene | PGK1 | C0684324 | Deficiency of phosphoglycerate kinase | 1 | ORPHANET |
| Tgene | PGK1 | C1266042 | Chromophobe Renal Cell Carcinoma | 1 | CTD_human |
| Tgene | PGK1 | C1266043 | Sarcomatoid Renal Cell Carcinoma | 1 | CTD_human |
| Tgene | PGK1 | C1266044 | Collecting Duct Carcinoma of the Kidney | 1 | CTD_human |
| Tgene | PGK1 | C1306837 | Papillary Renal Cell Carcinoma | 1 | CTD_human |
| Tgene | PGK1 | C2239176 | Liver carcinoma | 1 | CTD_human |
Copyright 2021-Present -The University of Texas Health Science Center at Houston (UTHealth)
Web File Viewing | Emergency Information |Campus Carry|Site Policies